On July 22, AdvaMed® submitted a letter to Medicare Administrative Contractors (MACs), Novitas and First Coast Service Options, regarding proposed local coverage determinations (LCDs) on Genetic Testing in Oncology. Upon review of these draft LCDs, AdvaMed® identified a number of significant concerns that the current procedural requirements for LCDs were not properly followed. As a result, if finalized, these draft LCDs would result in a significant narrowing of coverage that is currently available to Medicare beneficiaries with cancer. AdvaMed® recommended that the MACs not finalize these LCDs and instead work with stakeholders and the Carrier Advisory Committee to receive input prior to development of a new policy.
For more information around AdvaMed®’s efforts around diagnostic test payment and coverage, please contact Tara Burke.